⌘K
Loading ticker…
Bio-Rad Laboratories, Inc.Class A · Healthcare · Measuring & Control Equipment
As of 2026-06-26, Bio-Rad Laboratories, Inc.Class A (BIO) has a 3-month relative strength percentile of 56 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 3.3%, relative volume 1.26×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
56 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
BIO is in a stage 1 base, week 6. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 6.2% / 2.4%.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
BIO is held by 12 ETFs as of Mar 2026. Top owner: IJH at 0.16% weight, $168M notional. Top 3 carry $453M.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| IJHiShares Core S&P Mid-Cap ETF | 0.16% | $168M |
| VTIVanguard Total Stock Market ETF | 0.01% | $165M |
| VBVanguard Small Cap ETF | 0.07% | $120M |
| VBRVanguard Small Cap Value ETF | 0.13% | $76M |
| VXFVanguard Extended Market ETF | 0.07% | $56M |
| MDYState Street SPDR S&P MIDCAP 400 ETF Trust | 0.16% | $38M |
| IWRiShares Russell Midcap ETF | 0.04% | $20M |
| IWDiShares Russell 1000 Value ETF | 0.02% | $12M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.01% | $7M |
| IWBiShares Russell 1000 ETF | 0.01% | $4M |
Showing 10 of 12 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BIO Jan avg: 4.33% median: 4.62% win: 50% σ: 7.22% n: 4 2022-04-12 → 2026-05-29 | BIO Feb avg: -6.99% median: -1.82% win: 50% σ: 13.45% n: 4 2022-04-12 → 2026-05-29 | BIO Mar avg: -0.41% median: 0.18% win: 75% σ: 5.87% n: 4 2022-04-12 → 2026-05-29 | BIO Apr avg: -8.07% median: -5.89% win: 40% σ: 9.58% n: 5 2022-04-12 → 2026-05-29 | BIO May avg: -0.26% median: 5.03% win: 60% σ: 11.65% n: 5 2022-04-12 → 2026-05-29 | BIO Jun avg: -1.22% median: -1.62% win: 50% σ: 6.40% n: 4 2022-04-12 → 2026-05-29 (current) | BIO Jul avg: 11.22% median: 10.36% win: 100% σ: 10.10% n: 4 2022-04-12 → 2026-05-29 | BIO Aug avg: 1.91% median: -0.79% win: 25% σ: 15.43% n: 4 2022-04-12 → 2026-05-29 | BIO Sep avg: -7.78% median: -8.15% win: 0% σ: 5.71% n: 4 2022-04-12 → 2026-05-29 | BIO Oct avg: -4.47% median: -4.31% win: 50% σ: 17.79% n: 4 2022-04-12 → 2026-05-29 | BIO Nov avg: 6.35% median: 6.21% win: 75% σ: 10.04% n: 4 2022-04-12 → 2026-05-29 | BIO Dec avg: -0.74% median: -1.07% win: 50% σ: 5.54% n: 4 2022-04-12 → 2026-05-29 |